Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Film Formers & Plasticizers
Solubilizers
Emulsifying Agents
Thickeners and Stabilizers
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Etomidate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etomidate, including repackagers and relabelers. The FDA regulates Etomidate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etomidate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etomidate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etomidate supplier is an individual or a company that provides Etomidate active pharmaceutical ingredient (API) or Etomidate finished formulations upon request. The Etomidate suppliers may include Etomidate API manufacturers, exporters, distributors and traders.
click here to find a list of Etomidate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Etomidate DMF (Drug Master File) is a document detailing the whole manufacturing process of Etomidate active pharmaceutical ingredient (API) in detail. Different forms of Etomidate DMFs exist exist since differing nations have different regulations, such as Etomidate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Etomidate DMF submitted to regulatory agencies in the US is known as a USDMF. Etomidate USDMF includes data on Etomidate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Etomidate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Etomidate suppliers with USDMF on PharmaCompass.
A Etomidate CEP of the European Pharmacopoeia monograph is often referred to as a Etomidate Certificate of Suitability (COS). The purpose of a Etomidate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Etomidate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Etomidate to their clients by showing that a Etomidate CEP has been issued for it. The manufacturer submits a Etomidate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Etomidate CEP holder for the record. Additionally, the data presented in the Etomidate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Etomidate DMF.
A Etomidate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Etomidate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Etomidate suppliers with CEP (COS) on PharmaCompass.
A Etomidate written confirmation (Etomidate WC) is an official document issued by a regulatory agency to a Etomidate manufacturer, verifying that the manufacturing facility of a Etomidate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Etomidate APIs or Etomidate finished pharmaceutical products to another nation, regulatory agencies frequently require a Etomidate WC (written confirmation) as part of the regulatory process.
click here to find a list of Etomidate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Etomidate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Etomidate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Etomidate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Etomidate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Etomidate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Etomidate suppliers with NDC on PharmaCompass.
Etomidate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etomidate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etomidate GMP manufacturer or Etomidate GMP API supplier for your needs.
A Etomidate CoA (Certificate of Analysis) is a formal document that attests to Etomidate's compliance with Etomidate specifications and serves as a tool for batch-level quality control.
Etomidate CoA mostly includes findings from lab analyses of a specific batch. For each Etomidate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etomidate may be tested according to a variety of international standards, such as European Pharmacopoeia (Etomidate EP), Etomidate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etomidate USP).
LOOKING FOR A SUPPLIER?
